Zenas Biopharma
$32.32
23
+$1.05+3.36% Monday 20:00
+$0.00+0%Monday 23:30After hours
Statistics
Day High
32.5
Day Low
32.24
52W High
44.6
52W Low
13.5
Volume
35,799
Avg. Volume
-
Mkt Cap
2.11B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Jan 20
$0.00
Oct 19
$0.02
Jul 19
$0.02
Mar 19
$0.01
Jan 19
$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
18NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.77
-1.45
-1.12
-0.8
Expected EPS
-1.215912
Actual EPS
N/A
Financials
-3,777.37%Profit Margin
Unprofitable10MRevenue
-377.74MNet Income
Analyst Ratings
43.40Average Price Target
The highest estimate is 55.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 80%
Hold 20%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ZBIO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Holdings
About
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
Show more...
CEO
Leon Oliver Moulder Jr.
Employees
167
Country
United States
ISIN
US98937L1052
Listings
0 Comments
Share your thoughts
FAQ
What is Zenas Biopharma stock price today?▼
The current price of ZBIO is $32.32 USD — it has increased by +3.36% in the past 24 hours. Watch Zenas Biopharma stock price performance more closely on the chart.
What is Zenas Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Zenas Biopharma stocks are traded under the ticker ZBIO.
Is Zenas Biopharma stock price growing?▼
ZBIO stock has fallen by -4.29% compared to the previous week, the month change is a +2.8% rise, over the last year Zenas Biopharma has showed a +102% increase.
What is Zenas Biopharma market cap?▼
Today Zenas Biopharma has the market capitalization of 2.11B
When is the next Zenas Biopharma earnings date?▼
Zenas Biopharma is going to release the next earnings report on November 18, 2026.
What were Zenas Biopharma earnings last quarter?▼
ZBIO earnings for the last quarter are -1.77 USD per share, whereas the estimation was -1.12 USD resulting in a -57.71% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Zenas Biopharma revenue for the last year?▼
Zenas Biopharma revenue for the last year amounts to 10M USD.
What is Zenas Biopharma net income for the last year?▼
ZBIO net income for the last year is -377.74M USD.
Does Zenas Biopharma pay dividends?▼
Yes, ZBIO dividends are paid quarterly. The last dividend per share was 0 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Zenas Biopharma have?▼
As of September 01, 2026, the company has 167 employees.
In which sector is Zenas Biopharma located?▼
Zenas Biopharma operates in the Health & Wellness sector.
When did Zenas Biopharma complete a stock split?▼
The last stock split for Zenas Biopharma was on May 24, 2018 with a ratio of 1:2.
Where is Zenas Biopharma headquartered?▼
Zenas Biopharma is headquartered in WALTHAM, United States.